NASDAQ: GRI - GRI Bio, Inc.

Yield per half year: -37.44%
Sector: Healthcare

Share chart GRI Bio, Inc.

Extended chart Simple chart
Financial Markets by TradingView

About

GRI Bio, Inc., биофармацевтическая компания клинической стадии, специализируется на лечении воспалительных, фиброзных и аутоиммунных заболеваний в Соединенных Штатах. В портфель продуктов компании входят GRI-0621, который находится на стадии II клинической разработки для лечения идиопатического легочного фиброза; GRI-0803, который проходит фазу I испытаний по лечению системной красной волчанки; GRI-0124, находящийся в доклинической разработке для лечения первичного склерозирующего холангита; и GRI-0729 в ​​доклинической разработке.

More details
Компания также разрабатывает ADAIR и ADMIR для лечения синдрома дефицита внимания и гиперактивности. GRI Bio, Inc. ранее была известна как Glycoregimmune, Inc. GRI Bio, Inc. была основана в 2009 году и базируется в Лос-Анджелес-Хойя, Калифорния.

Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

Цена ао 0.7525
Выручка 0.0001
EBITDA -0.0032
EV/EBITDA 1.1
P/BV -0.000144
Сайт https://www.gribio.com
Число акций ао 0.0004616 млрд
Валюта usd
IPO date 2021-02-10
Sector Health Care
Industry Biotechnology
Валюта отчета usd
P/S 0.6522
Change price per day: -6.94% (0.3763)
Change price per week: -21.48% (0.446)
Change price per month: -28.53% (0.49)
Change price per 3 month: -78.65% (1.64)
Change price per half year: -37.44% (0.5598)
Change price per year: -96.81% (10.99)
Change price per 3 year: -94.68% (6.58)
Change price per year to date: -96.06% (8.89)
All parameters

Underestimation

Title Value Grade
P/S 0.6522 10
P/BV 54.81 1
P/E 0 0
EV/EBITDA -1.09 0
Total: 5.13

Efficiency

Title Value Grade
ROA, % -441.04 0
ROE, % -5033.59 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -0.0012 10
Total: 10

Growth impulse

Title Value Grade
Yield Revenue, % 21667 10
Yield Ebitda, % 254.06 10
Yield EPS, % -73.56 0
Total: 8
More

Institutions Volume Share, %
Altium Capital Management, LP 74501 1.65
Stratos Wealth Partners, Ltd. 3571 0.08
HRT Financial LP 3425 0.08
Vanguard Group Inc 2648 0.06
Geode Capital Management, LLC 2124 0.05
Tower Research Capital LLC (TRC) 1062 0.02
UBS Group AG 342 0.01
Wells Fargo & Company 2 0

ETF Share, % Profitability for 1 year, % Dividends, %
Avantis International Equity ETF 0.01689 9.1570019041025 3.80856
Avantis Responsible International Equity ETF 0.03104 17.439426322833 3.61591
WisdomTree Dynamic Currency Hedged International SmallCap Equity Fund 0.16295 12.23506743738 5.2239
WisdomTree Dynamic Currency Hedged International Equity Fund 0.01553 10.932475884244 4.7092
Dimensional International Core Equity Market ETF 0.01321 13.085145595282 3.48343
Dimensional World ex U.S. Core Equity 2 ETF 0.01949 13.062098501071 3.62488
Dimensional International Core Equity 2 ETF 0.03471 12.593206296603 3.69996
Dimensional International Small Cap ETF 0.10078 13.318681318681 3.34747
Dimensional International Small Cap Value ETF 0.33137 13.61043194784 4.55441
WisdomTree International SmallCap Dividend Fund 0.17136 8.5202544358888 5.22973
Schwab Fundamental International Small Co. Index ETF 0.03575 8.3132530120482 3.46652
DBX ETF Trust - Xtrackers International Real Estate ETF 0.23773 3.115234375 4.01983
Invesco FTSE RAFI Developed Markets ex-U.S. Small-Mid ETF 0.07311 6.0617916715573 3.5165
SPDR Dow Jones Global Real Estate ETF 0.15319 16.289592760181 4.1185
SPDR Dow Jones International Real Estate ETF 0.54326 -2.4750499001996 4.62416
Schwab International Small-Cap Equity ETF 0.10471 10.066046232363 3.20638
SPDR Portfolio Europe ETF 0.01577 8.9403102813568 3.66537
FlexShares Morningstar Developed Markets ex-US Factor Tilt Index Fund 0.02317 8.7236182447735 3.85434
Vanguard ESG International Stock ETF 0.01 10.20253643763 3.07501
Vanguard FTSE All-World ex-US Small-Cap ETF 0.07 9.3937465915288 3.09932



Head Job title Payment Year of birth
Dr. W. Marc Hertz Ph.D. President & Director 842.01k 1970 (54 years)
Ms. Leanne M. Kelly CFO & Corporate Secretary 550.93k 1977 (47 years)
Dr. Vipin Kumar Chaturvedi Ph.D. Co-Founder & Chief Scientific Officer N/A 1959 (65 years)
Dr. Albert Agro Ph.d. Co-Founder & Chief Medical Officer 461.1k 1965 (59 years)
Ms. Cristina Gil White Interim Chief Executive Officer

Address: United States, LA Jolla. CA, 2223 Avenida de la Playa - open in Google maps, open in Yandex maps
Website: https://www.gribio.com